Raymedica Gets $12M in New Funding
Wednesday, December 27, 2006 9:00:00 AM PDT | VentureDeal Staff
MINNEAPOLIS, MN -- Raymedica, Inc. has received $12,000,000 in a new funding round, according to a regulatory filing.
The company was established in 1990 and is focused on the development and manufacture of its spinal disc solution Nucleus ArthroplastyTM for degenerative spinal disc disease and disc herniations.
The Stephens Group and Viscogliosi Brothers, LLC invested in the round.
Email Page | Print Page